–
Тезисы докладов
-
- 2022 784 Immune profiling of patients with advanced melanoma intratumorally treated with CV8102 as a single-agent or in combination with anti-PD-1 antibodies – results of a phase I trial expansion
- Gonzalez Marina, Wengenmayer Peter, Samoylenko Igor, Ochsenreither Sebastian, Richtig Erika, Thomas Ioannis, Erdmann Michael, Lebbe Celeste, Martin-Liberal Juan, Terheyden Patrick, Poltoratskiy Artem, Sekacheva Marina, Semiletova Yuliya, Eigentler Thomas, Schmitt-Bormann Beate, Vahrenhorst Dominik, Kays Sarah-Katharina, Seibel Tobias, Quintini Gianluca, Scheel Birgit, Falk Martin, Gnad-Vogt Ulrike, Codó Paula
- в сборнике Regular and Young Investigator Award Abstracts, издательство BMJ Publishing Group (United Kingdom), тезисы, с. A816-A816 DOI